UniProt ID | CAN2_HUMAN | |
---|---|---|
UniProt AC | P17655 | |
Protein Name | Calpain-2 catalytic subunit | |
Gene Name | CAPN2 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 700 | |
Subcellular Localization | Cytoplasm. Cell membrane. Translocates to the plasma membrane upon Ca(2+) binding. | |
Protein Description | Calcium-regulated non-lysosomal thiol-protease which catalyzes limited proteolysis of substrates involved in cytoskeletal remodeling and signal transduction. Proteolytically cleaves MYOC at 'Arg-226'. [PubMed: 17650508 Proteolytically cleaves CPEB3 following neuronal stimulation which abolishes CPEB3 translational repressor activity, leading to translation of CPEB3 target mRNAs (By similarity] | |
Protein Sequence | MAGIAAKLAKDREAAEGLGSHDRAIKYLNQDYEALRNECLEAGTLFQDPSFPAIPSALGFKELGPYSSKTRGIEWKRPTEICADPQFIIGGATRTDICQGALGDCWLLAAIASLTLNEEILARVVPLNQSFQENYAGIFHFQFWQYGEWVEVVVDDRLPTKDGELLFVHSAEGSEFWSALLEKAYAKINGCYEALSGGATTEGFEDFTGGIAEWYELKKPPPNLFKIIQKALQKGSLLGCSIDITSAADSEAITFQKLVKGHAYSVTGAEEVESNGSLQKLIRIRNPWGEVEWTGRWNDNCPSWNTIDPEERERLTRRHEDGEFWMSFSDFLRHYSRLEICNLTPDTLTSDTYKKWKLTKMDGNWRRGSTAGGCRNYPNTFWMNPQYLIKLEEEDEDEEDGESGCTFLVGLIQKHRRRQRKMGEDMHTIGFGIYEVPEELSGQTNIHLSKNFFLTNRARERSDTFINLREVLNRFKLPPGEYILVPSTFEPNKDGDFCIRVFSEKKADYQAVDDEIEANLEEFDISEDDIDDGFRRLFAQLAGEDAEISAFELQTILRRVLAKRQDIKSDGFSIETCKIMVDMLDSDGSGKLGLKEFYILWTKIQKYQKIYREIDVDRSGTMNSYEMRKALEEAGFKMPCQLHQVIVARFADDQLIIDFDNFVRCLVRLETLFKIFKQLDPENTGTIELDLISWLCFSVL | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MAGIAAKLA ------CCCHHHHHH | 20.35 | 22814378 | |
7 | Acetylation | -MAGIAAKLAKDREA -CCCHHHHHHHHHHH | 39.70 | 23236377 | |
23 | Methylation | EGLGSHDRAIKYLNQ HCCCCHHHHHHHHHH | 32.56 | - | |
26 | Ubiquitination | GSHDRAIKYLNQDYE CCHHHHHHHHHHHHH | 42.58 | 21890473 | |
32 | Phosphorylation | IKYLNQDYEALRNEC HHHHHHHHHHHHHHH | 8.04 | 27642862 | |
50 | Phosphorylation | GTLFQDPSFPAIPSA CCCCCCCCCCCCCHH | 52.75 | 14993287 | |
61 | Acetylation | IPSALGFKELGPYSS CCHHCCCHHHCCCCC | 50.67 | 156195 | |
61 | Ubiquitination | IPSALGFKELGPYSS CCHHCCCHHHCCCCC | 50.67 | - | |
67 | Phosphorylation | FKELGPYSSKTRGIE CHHHCCCCCCCCCCC | 28.61 | 29514088 | |
68 | Phosphorylation | KELGPYSSKTRGIEW HHHCCCCCCCCCCCC | 32.00 | 25159151 | |
69 | Ubiquitination | ELGPYSSKTRGIEWK HHCCCCCCCCCCCCC | 35.98 | 21890473 | |
76 | Acetylation | KTRGIEWKRPTEICA CCCCCCCCCCCCCCC | 35.39 | 26051181 | |
82 | Glutathionylation | WKRPTEICADPQFII CCCCCCCCCCCCEEE | 2.60 | 22555962 | |
82 | S-nitrosylation | WKRPTEICADPQFII CCCCCCCCCCCCEEE | 2.60 | 2212679 | |
182 (in isoform 2) | Ubiquitination | - | 36.17 | - | |
219 | Ubiquitination | AEWYELKKPPPNLFK HHHHHCCCCCCCHHH | 75.32 | - | |
230 | Ubiquitination | NLFKIIQKALQKGSL CHHHHHHHHHHCCCC | 40.43 | - | |
230 | Malonylation | NLFKIIQKALQKGSL CHHHHHHHHHHCCCC | 40.43 | 26320211 | |
234 | Ubiquitination | IIQKALQKGSLLGCS HHHHHHHCCCCCCCE | 51.85 | - | |
257 | Ubiquitination | SEAITFQKLVKGHAY CCCEEHHHHHCCCCE | 51.56 | - | |
260 | Acetylation | ITFQKLVKGHAYSVT EEHHHHHCCCCEECC | 56.25 | 26051181 | |
260 | Malonylation | ITFQKLVKGHAYSVT EEHHHHHCCCCEECC | 56.25 | 26320211 | |
260 | Ubiquitination | ITFQKLVKGHAYSVT EEHHHHHCCCCEECC | 56.25 | 21890473 | |
264 | Phosphorylation | KLVKGHAYSVTGAEE HHHCCCCEECCCCEE | 9.67 | 28152594 | |
265 | Phosphorylation | LVKGHAYSVTGAEEV HHCCCCEECCCCEEE | 17.62 | 28152594 | |
267 | Phosphorylation | KGHAYSVTGAEEVES CCCCEECCCCEEECC | 25.41 | 28152594 | |
274 | Phosphorylation | TGAEEVESNGSLQKL CCCEEECCCCCEEEE | 52.22 | 27251275 | |
277 | Phosphorylation | EEVESNGSLQKLIRI EEECCCCCEEEEEEE | 31.70 | 27251275 | |
280 | Acetylation | ESNGSLQKLIRIRNP CCCCCEEEEEEEECC | 51.69 | 26051181 | |
280 | Malonylation | ESNGSLQKLIRIRNP CCCCCEEEEEEEECC | 51.69 | 26320211 | |
280 | Ubiquitination | ESNGSLQKLIRIRNP CCCCCEEEEEEEECC | 51.69 | 21906983 | |
326 | Sulfoxidation | HEDGEFWMSFSDFLR CCCCCEEECHHHHHH | 3.35 | 30846556 | |
344 | Phosphorylation | RLEICNLTPDTLTSD CCCCCCCCCCCCCCC | 12.72 | 21406692 | |
347 | Phosphorylation | ICNLTPDTLTSDTYK CCCCCCCCCCCCHHH | 32.89 | 21406692 | |
349 | Phosphorylation | NLTPDTLTSDTYKKW CCCCCCCCCCHHHCE | 27.01 | 21406692 | |
350 | Phosphorylation | LTPDTLTSDTYKKWK CCCCCCCCCHHHCEE | 30.94 | 21406692 | |
352 | Phosphorylation | PDTLTSDTYKKWKLT CCCCCCCHHHCEEEE | 36.69 | 21406692 | |
353 | Phosphorylation | DTLTSDTYKKWKLTK CCCCCCHHHCEEEEE | 18.63 | 28152594 | |
354 | Ubiquitination | TLTSDTYKKWKLTKM CCCCCHHHCEEEEEC | 55.01 | - | |
354 | Acetylation | TLTSDTYKKWKLTKM CCCCCHHHCEEEEEC | 55.01 | 7609103 | |
355 | Acetylation | LTSDTYKKWKLTKMD CCCCHHHCEEEEECC | 38.86 | 15609665 | |
359 | Phosphorylation | TYKKWKLTKMDGNWR HHHCEEEEECCCCCC | 22.16 | 21601212 | |
360 | Ubiquitination | YKKWKLTKMDGNWRR HHCEEEEECCCCCCC | 45.49 | 21906983 | |
369 | Phosphorylation | DGNWRRGSTAGGCRN CCCCCCCCCCCCCCC | 17.17 | 27273156 | |
370 | Phosphorylation | GNWRRGSTAGGCRNY CCCCCCCCCCCCCCC | 31.95 | 27251275 | |
377 | Phosphorylation | TAGGCRNYPNTFWMN CCCCCCCCCCCCEEC | 4.40 | 27251275 | |
380 | Phosphorylation | GCRNYPNTFWMNPQY CCCCCCCCCEECHHH | 17.73 | 27251275 | |
383 | Sulfoxidation | NYPNTFWMNPQYLIK CCCCCCEECHHHEEE | 4.59 | 30846556 | |
390 | Sumoylation | MNPQYLIKLEEEDED ECHHHEEECCCCCCC | 47.45 | - | |
390 | Sumoylation | MNPQYLIKLEEEDED ECHHHEEECCCCCCC | 47.45 | - | |
398 (in isoform 2) | Ubiquitination | - | 56.81 | - | |
403 | Phosphorylation | EDEEDGESGCTFLVG CCCCCCCCCHHHHHH | 44.70 | 21712546 | |
405 | Glutathionylation | EEDGESGCTFLVGLI CCCCCCCHHHHHHHH | 3.19 | 22555962 | |
406 | Phosphorylation | EDGESGCTFLVGLIQ CCCCCCHHHHHHHHH | 24.43 | 27251275 | |
414 | Acetylation | FLVGLIQKHRRRQRK HHHHHHHHHHHHHHH | 31.89 | 26051181 | |
414 | Ubiquitination | FLVGLIQKHRRRQRK HHHHHHHHHHHHHHH | 31.89 | - | |
434 | Phosphorylation | HTIGFGIYEVPEELS CCCCCEEEECCHHHC | 15.97 | 27642862 | |
450 | Ubiquitination | QTNIHLSKNFFLTNR CCCEEEECCEEECCC | 65.22 | - | |
462 | Phosphorylation | TNRARERSDTFINLR CCCHHHHCCCEECHH | 35.93 | 29255136 | |
464 | Phosphorylation | RARERSDTFINLREV CHHHHCCCEECHHHH | 27.88 | 29255136 | |
476 | Ubiquitination | REVLNRFKLPPGEYI HHHHHHCCCCCCCEE | 57.77 | 21890473 | |
568 | Ubiquitination | LAKRQDIKSDGFSIE HHHCCCCCCCCCEEE | 51.27 | - | |
569 | Phosphorylation | AKRQDIKSDGFSIET HHCCCCCCCCCEEEE | 43.21 | 21712546 | |
577 | S-nitrosylation | DGFSIETCKIMVDML CCCEEEEEEEEEEEE | 1.50 | 2212679 | |
580 | Sulfoxidation | SIETCKIMVDMLDSD EEEEEEEEEEEECCC | 0.97 | 30846556 | |
583 | Sulfoxidation | TCKIMVDMLDSDGSG EEEEEEEEECCCCCC | 2.81 | 30846556 | |
586 | Phosphorylation | IMVDMLDSDGSGKLG EEEEEECCCCCCCCC | 39.65 | - | |
589 | Phosphorylation | DMLDSDGSGKLGLKE EEECCCCCCCCCCEE | 37.43 | 21712546 | |
591 | Ubiquitination | LDSDGSGKLGLKEFY ECCCCCCCCCCEEEH | 40.87 | - | |
595 | Ubiquitination | GSGKLGLKEFYILWT CCCCCCCEEEHHHHH | 43.93 | - | |
596 (in isoform 2) | Ubiquitination | - | 49.04 | - | |
607 | Phosphorylation | LWTKIQKYQKIYREI HHHHHHHHHHHHHHC | 9.92 | 26074081 | |
611 | Phosphorylation | IQKYQKIYREIDVDR HHHHHHHHHHCCCCC | 14.83 | 26074081 | |
619 | Phosphorylation | REIDVDRSGTMNSYE HHCCCCCCCCCCHHH | 33.87 | 26074081 | |
621 | Phosphorylation | IDVDRSGTMNSYEMR CCCCCCCCCCHHHHH | 17.90 | 26074081 | |
624 | Phosphorylation | DRSGTMNSYEMRKAL CCCCCCCHHHHHHHH | 16.20 | 26074081 | |
625 | Phosphorylation | RSGTMNSYEMRKALE CCCCCCHHHHHHHHH | 14.56 | 26074081 | |
629 | Ubiquitination | MNSYEMRKALEEAGF CCHHHHHHHHHHCCC | 56.89 | - | |
637 | Acetylation | ALEEAGFKMPCQLHQ HHHHCCCCCCCEEEH | 40.80 | 26051181 | |
637 | Ubiquitination | ALEEAGFKMPCQLHQ HHHHCCCCCCCEEEH | 40.80 | - | |
638 | Sulfoxidation | LEEAGFKMPCQLHQV HHHCCCCCCCEEEHH | 3.61 | 30846556 | |
674 | Ubiquitination | VRLETLFKIFKQLDP HHHHHHHHHHHHCCC | 50.80 | 21890473 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
50 | S | Phosphorylation | Kinase | MAPK1 | P28482 | GPS |
50 | S | Phosphorylation | Kinase | MAPK3 | P27361 | GPS |
369 | S | Phosphorylation | Kinase | PRKACA | P17612 | GPS |
369 | S | Phosphorylation | Kinase | PKA-FAMILY | - | GPS |
369 | S | Phosphorylation | Kinase | PKA_GROUP | - | PhosphoELM |
370 | T | Phosphorylation | Kinase | PRKACA | P17612 | GPS |
370 | T | Phosphorylation | Kinase | PKA-FAMILY | - | GPS |
370 | T | Phosphorylation | Kinase | PKA_GROUP | - | PhosphoELM |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of CAN2_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of CAN2_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
CPNS1_HUMAN | CAPNS1 | physical | 11517928 | |
BCL2_HUMAN | BCL2 | physical | 12000759 | |
BID_HUMAN | BID | physical | 12000759 | |
PTPRN_HUMAN | PTPRN | physical | 11483505 | |
TAU_HUMAN | MAPT | physical | 14993287 | |
ASNS_HUMAN | ASNS | physical | 22863883 | |
PUR9_HUMAN | ATIC | physical | 22863883 | |
LIS1_HUMAN | PAFAH1B1 | physical | 22863883 | |
PAPS1_HUMAN | PAPSS1 | physical | 22863883 | |
PLPHP_HUMAN | PROSC | physical | 22863883 | |
PTMA_HUMAN | PTMA | physical | 22863883 | |
RUXE_HUMAN | SNRPE | physical | 22863883 | |
TBB2A_HUMAN | TUBB2A | physical | 22863883 | |
EFTU_HUMAN | TUFM | physical | 22863883 | |
UBXN1_HUMAN | UBXN1 | physical | 22863883 | |
XPO1_HUMAN | XPO1 | physical | 22863883 | |
1433E_HUMAN | YWHAE | physical | 22863883 | |
UBC9_HUMAN | UBE2I | physical | 23395904 | |
ATG5_HUMAN | ATG5 | physical | 16998475 | |
ATX3_HUMAN | ATXN3 | physical | 27731380 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...